Substituted propenyl piperazine derivatives as novel inhibitors of histone deacetylase

Details for Australian Patent Application No. 2005266311 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Marconnet-Decrane, Laurence Francoise Bernadette; Van Emelen, Kristof; Angibaud, Patrick Rene; Van Brandt, Sven Franciscus Anna; Arts, Janine

Agent Shelston IP

Pub. Number AU-B-2005266311

PCT Pub. Number WO2006/010749

Priority 04077171.9 28.07.04 EP; 60/592,357 29.07.04 US

Filing date 25 July 2005

Wipo publication date 2 February 2006

Acceptance publication date 11 August 2011

International Classifications

C07D 239/42 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 31/505 (2006.01) - Pyrimidines

A61P 35/00 (2006.01) Antineoplastic agents

C07D 239/54 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

8 March 2007 PCT application entered the National Phase

  PCT publication WO2006/010749 Priority application(s): WO2006/010749

11 August 2011 Application Accepted

  Published as AU-B-2005266311

8 December 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005266312-Substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase

2005266310-Pharmaceutical combinations containing an inhibitor of platelet aggregation and a fibrate